echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Active Ingredient News > Study of Nervous System > Annals of Neurology : NT1 Tau can be used as a specific, early marker of Alzheimer's disease

    Annals of Neurology : NT1 Tau can be used as a specific, early marker of Alzheimer's disease

    • Last Update: 2021-01-12
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com
    It is necessary to look for sensitive, widely used, blood-based screening methods to identify patients with AD in the early stages of symptoms.
    David Mengel of Harvard University, among others, recently developed an ultra-sensitive immunoanalytation technique, NT1 tau, to detect tau proteins captured by mid-region antibody BT2 (194-198) and to test with n-end antibody taut12.
    the name NT1 is not a trademark, but is used to distinguish between their detection methods and other N-side tau detection methods, not all N-side tau detection methods detect the same tau molecular form.
    , the molecular heterogeneity of tau proteins makes the comparison between test results based on different anti-tau protein combinations challenging.
    In a previous study, NT1 analysis was better able to distinguish AD and AD-MCI (mild cognitive impairment) from the control group than indoor analysis, which used monoclonal antibodies the same as Quanterix analysis, and effectively distinguished between AD and control groups in two separate coding regions, NT1 tau.
    addition, the nerve fiber light chain (NfL) is a particularly rich cytostebrae component of neurons in axons.
    NfL levels increased in many neurodegenerative diseases, and several studies have found elevated levels of NfL in simple AD or preclinical AD, serum and plasma.
    , the baseline NfL was also higher in patients with AD and non-AD dementia than in the control group.
    tested NT1 tau and NfL levels in plasma in THEI, AD dementia, non-AD dementia, and control groups.
    showed a significant increase in NT1 tau levels in AD compared to the control group, but not in non-AD.
    but NfL increased significantly in both AD and non-AD dementia.
    NT1 tau levels were higher in patients who developed AD dementia from MCI.
    the significance of this study is that plasma NT1 tau was found to be a more specific marker of AD (as opposed to NfL), elevated in the early stages of the disease, and can be used as a first round of screening to identify individuals at risk of AD.
    origins: Mengel, D., Janelidze, S., Glynn, R.J., Liu, W., Hansson, O., and Walsh, D.M. (2020). Plasma NT1 Tau is a Specific and Early Marker of Alzheimer's Disease. Annals of Neurology, 88(5), 878-892.<!--5f39ae17-8c62-4a45-bc43-b32064c9388a: W3siYmxvY2tJZCI6IjE4NjEtMTYxMDMxODczMDYwMyIsImJsb2NrVHlwZSI6InBhcmFncmFwaCIsInN0eWxlcyI6eyJhbGlnbiI6ImxlZnQiLCJpbmRlbnQiOjAsInRleHQtaW5kZW50IjowLCJsaW5lLWhlaWdodCI6MS43NSwiYmFjay1jb2xvciI6IiIsInBhZGRpbmciOiIifSwidHlwZSI6InBhcmFncmFwaCIsInJpY2hUZXh0Ijp7ImRhdGEiOlt7ImNoYXIiOiIgIiwic3R5bGVzIjp7ImZvbnQtc2l6ZSI6MTYsImNvbG9yIjoiIzFjMWQxZSIsImJhY2stY29sb3IiOiIjZmZmZmZmIn19LHsiY2hhciI6IkEiLCJzdHlsZXMiOnsiZm9udC1zaXplIjoxN。 iwiY29sb3IiOiIjMWMxZDFlIiwiYmFjay1jb2xvciI6IiNmZmZmZmYifX0seyJjaGFyIjoibiIsInN0eWxlcyI6eyJmb250LXNpemUiOjE2LCJjb2xvciI6IiMxYzFkMWUiLCJiYWNrLWNvbG9yIjoiI2ZmZmZmZiJ9fSx7ImNoYXIiOiJuIiwic3R5bGVzIjp7ImZvbnQtc2l6ZSI6MTYsImNvbG9yIjoiIzFjMWQxZSIsImJhY2stY29sb3IiOiIjZmZmZmZmIn19LHsiY2hhciI6ImEiLCJzdHlsZXMiOnsiZm9udC1zaXplIjoxNiwiY29sb3IiOiIjMWMxZDFlIiwiYmFjay1jb2xvciI6IiNmZmZmZmYifX0seyJjaGFyIjoibCIsInN0eWxlcyI6eyJmb250LX。 NpemUiOjE2LCJjb2xvciI6IiMxYzFkMWUiLCJiYWNrLWNvbG9yIjoiI2ZmZmZmZiJ9fSx7ImNoYXIiOiJzIiwic3R5bGVzIjp7ImZvbnQtc2l6ZSI6MTYsImNvbG9yIjoiIzFjMWQxZSIsImJhY2stY29sb3IiOiIjZmZmZmZmIn19LHsiY2hhciI6IiAiLCJzdHlsZXMiOnsiZm9udC1zaXplIjoxNiwiY29sb3IiOiIjMWMxZDFlIiwiYmFjay1jb2xvciI6IiNmZmZmZmYifX0seyJjaGFyIjoibyIsInN0eWxlcyI6eyJmb250LXNpemUiOjE2LCJjb2xvciI6IiMxYzFkMWUiLCJiYWNrLWNvbG9yIjoiI2ZmZmZmZiJ9fSx7ImNoYXIiOiJmIiwic3R5bGVzIjp。 7ImZvbnQtc2l6ZSI6MTYsImNvbG9yIjoiIzFjMWQxZSIsImJhY2stY29sb3IiOiIjZmZmZmZmIn19LHsiY2hhciI6IiAiLCJzdHlsZXMiOnsiZm9udC1zaXplIjoxNiwiY29sb3IiOiIjMWMxZDFlIiwiYmFjay1jb2xvciI6IiNmZmZmZmYifX0seyJjaGFyIjoiICIsInN0eWxlcyI6eyJmb250LXNpemUiOjE2LCJjb2xvciI6IiMxYzFkMWUiLCJiYWNrLWNvbG9yIjoiI2ZmZmZmZiJ9fSx7ImNoYXIiOiJOIiwic3R5bGVzIjp7ImZvbnQtc2l6ZSI6MTYsImNvbG9yIjoiIzFjMWQxZSIsImJhY2stY29sb3IiOiIjZmZmZmZmIn19LHsiY2hhciI6ImUiLCJz。 dHlsZXMiOnsiZm9udC1zaXplIjoxNiwiY29sb3IiOiIjMWMxZDFlIiwiYmFjay1jb2xvciI6IiNmZmZmZmYifX0seyJjaGFyIjoidSIsInN0eWxlcyI6eyJmb250LXNpemUiOjE2LCJjb2xvciI6IiMxYzFkMWUiLCJiYWNrLWNvbG9yIjoiI2ZmZmZmZiJ9fSx7ImNoYXIiOiJyIiwic3R5bGVzIjp7ImZvbnQtc2l6ZSI6MTYsImNvbG9yIjoiIzFjMWQxZSIsImJhY2stY29sb3IiOiIjZmZmZmZmIn19LHsiY2hhciI6Im8iLCJzdHlsZXMiOnsiZm9udC1zaXplIjoxNiwiY29sb3IiOiIjMWMxZDFlIiwiYmFjay1jb2xvciI6IiNmZmZmZmYifX0seyJjaGFyI。 joibCIsInN0eWxlcyI6eyJmb250LXNpemUiOjE2LCJjb2xvciI6IiMxYzFkMWUiLCJiYWNrLWNvbG9yIjoiI2ZmZmZmZiJ9fSx7ImNoYXIiOiJvIiwic3R5bGVzIjp7ImZvbnQtc2l6ZSI6MTYsImNvbG9yIjoiIzFjMWQxZSIsImJhY2stY29sb3IiOiIjZmZmZmZmIn19LHsiY2hhciI6ImciLCJzdHlsZXMiOnsiZm9udC1zaXplIjoxNiwiY29sb3IiOiIjMWMxZDFlIiwiYmFjay1jb2xvciI6IiNmZmZmZmYifX0seyJjaGFyIjoieSIsInN0eWxlcyI6eyJmb250LXNpemUiOjE2LCJjb2xvciI6IiMxYzFkMWUiLCJiYWNrLWNvbG9yIjoiI2ZmZmZmZiJ9fS。 x7ImNoYXIiOiIgIiwic3R5bGVzIjp7ImZvbnQtc2l6ZSI6MTYsImNvbG9yIjoiIzFjMWQxZSIsImJhY2stY29sb3IiOiIjZmZmZmZmIn19LHsiY2hhciI6Iu+。 8miIsInN0eWxlcyI6eyJmb250LXNpemUiOjE2LCJjb2xvciI6IiMxYzFkMWUiLCJiYWNrLWNvbG9yIjoiI2ZmZmZmZiJ9fSx7ImNoYXIiOiIgIiwic3R5bGVzIjp7ImZvbnQtc2l6ZSI6MTYsImNvbG9yIjoiIzFjMWQxZSIsImJhY2stY29sb3IiOiIjZmZmZmZmIn19LHsiY2hhciI6Ik4iLCJzdHlsZXMiOnsiYmFjay1jb2xvciI6IiNmZmZmZmYifX0seyJjaGFyIjoiVCIsInN0eWxlcyI6eyJiYWNrLWNvbG9yIjoiI2ZmZmZmZiJ9fSx7ImNoYXIiOiIxIiwic3R5bGVzIjp7ImJhY2stY29sb3IiOiIjZmZmZmZmIn19LHsiY2hhciI6IiAiLCJzdHlsZXMi。 OnsiYmFjay1jb2xvciI6IiNmZmZmZmYifX0seyJjaGFyIjoiVCIsInN0eWxlcyI6eyJiYWNrLWNvbG9yIjoiI2ZmZmZmZiJ9fSx7ImNoYXIiOiJhIiwic3R5bGVzIjp7ImJhY2stY29sb3IiOiIjZmZmZmZmIn19LHsiY2hhciI6InUiLCJzdHlsZXMiOnsiYmFjay1jb2xvciI6IiNmZmZmZmYifX0seyJjaGFyIjoi5Y+。 vIiwic3R5bGVzIjp7ImJhY2stY29sb3IiOiIjZmZmZmZmIn19LHsiY2hhciI6IuS9nCIsInN0eWxlcyI6eyJiYWNrLWNvbG9yIjoiI2ZmZmZmZiJ9fSx7ImNoYXIiOiLkuLoiLCJzdHlsZXMiOnsiYmFjay1jb2xvciI6IiNmZmZmZmYifX0seyJjaGFyIjoi6Zi/ Iiwic3R5bGVzIjp7ImJhY2stY29sb3IiOiIjZmZmZmZmIn19LHsiY2hhciI6IuWwlCIsInN0eWxlcyI6eyJiYWNrLWNvbG9yIjoiI2ZmZmZmZiJ9fSx7ImNoYXIiOiLlhbkiLCJzdHlsZXMiOnsiYmFjay1jb2xvciI6IiNmZmZmZmYifX0seyJjaGFyIjoi5rW3Iiwic3R5bGVzIjp7ImJhY2stY29sb3IiOiIjZmZmZmZmIn19LHsiY2hhciI6Ium7mCIsInN0eWxlcyI6eyJiYWNrLWNvbG9yIjoiI2ZmZmZmZiJ9fSx7ImNoYXIiOiLnl4UiLCJzdHlsZXMiOnsiYmFjay1j。
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.